Journal article icon

Journal article

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Abstract:

BACKGROUND: Daily aspirin reduces the long-term incidence of some adenocarcinomas, but effects on mortality due to some cancers appear after only a few years, suggesting that it might also reduce growth or metastasis. We established the frequency of distant metastasis in patients who developed cancer during trials of daily aspirin versus control. METHODS: Our analysis included all five large randomised trials of daily aspirin (≥75 mg daily) versus control for the prevention of vascular events...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience, Biomedical Research Centre
Role:
Author
Expand authors...
Journal:
Lancet
Volume:
379
Issue:
9826
Pages:
1591-1601
Publication date:
2012-04-05
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
URN:
uuid:a3871e28-0e89-4c27-994c-15ff5c40e8a0
Source identifiers:
320385
Local pid:
pubs:320385

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP